Acknowledgments |
|
xiii | |
Foreword: Jesse's Intent |
|
xv | |
|
|
|
|
Preface |
|
xxv | |
|
|
|
|
|
|
|
|
Contributing Authors |
|
xxvii | |
PART 1 Background and Overview Topics |
|
2 | (31) |
|
An Ethics Primer for IRBs |
|
|
3 | (6) |
|
|
|
|
|
Reflections from the Office of the Inspector General |
|
|
9 | (4) |
|
|
|
|
|
A Unified Human-Research Protection Program |
|
|
13 | (4) |
|
|
|
|
|
A Shared Responsibility for Protecting Human Subjects |
|
|
17 | (5) |
|
|
|
|
|
The Tension Between Science and Ethics |
|
|
22 | (2) |
|
|
|
|
|
A Brief History of PRIM&R and IRB Education |
|
|
24 | (3) |
|
|
|
|
|
The IRB: Definition and Federal Oversight |
|
|
27 | (3) |
|
|
|
|
|
The Limits of IRB Authority |
|
|
30 | (3) |
|
|
|
|
PART 2 Organizing the Office |
|
33 | (44) |
|
Administrative Reporting Structure for the IRB |
|
|
35 | (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Documenting Compliance with Federal Regulations |
|
|
37 | (6) |
|
|
|
|
|
IRB Policies and Procedures |
|
|
43 | (7) |
|
|
|
|
|
|
50 | (8) |
|
|
|
|
|
|
58 | (8) |
|
|
|
|
|
|
66 | (9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75 | (2) |
|
|
|
|
|
|
|
|
|
|
|
|
PART 3 Organizing the IRB Committee |
|
77 | (32) |
|
Reflections on Chairing an IRB |
|
|
79 | (3) |
|
|
|
|
|
|
82 | (4) |
|
|
|
|
|
|
|
|
|
The IRB Administrative Director |
|
|
86 | (5) |
|
|
|
|
|
|
|
|
|
|
91 | (5) |
|
|
|
|
|
Committee Size, Alternates, and Consultants |
|
|
96 | (3) |
|
|
|
|
|
|
|
|
|
Length, Frequency, and Time of IRB Meetings |
|
|
99 | (2) |
|
|
|
|
|
|
|
|
|
|
101 | (4) |
|
|
|
|
|
|
|
|
|
Social Science Versus Biomedical IRBs |
|
|
105 | (4) |
|
|
|
|
|
|
|
|
PART 4 Review Categories Other Than Full Board Review |
|
109 | (32) |
|
|
111 | (3) |
|
|
|
|
|
|
|
|
|
|
114 | (4) |
|
|
|
|
|
|
|
|
|
Identifying Research Intent |
|
|
118 | (7) |
|
|
|
|
|
|
|
|
|
IRB Triage of Projects That Involve Medical Record Review |
|
|
125 | (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
``Compassionate Use'' and Emergency Exemption from IRB Approval |
|
|
129 | (3) |
|
|
|
|
|
|
|
|
|
Waiver of Consent in Emergency Medicine Research |
|
|
132 | (9) |
|
|
|
|
PART 5 Initial Protocol Review and the Full-Committee Meeting |
|
141 | (90) |
|
Overview of Initial Protocol Review |
|
|
143 | (9) |
|
|
|
|
|
Evaluating Study Design and Quality |
|
|
152 | (3) |
|
|
|
|
|
The Study Population: Women, Minorities, and Children |
|
|
155 | (5) |
|
|
|
|
|
Community Consultation to Evaluate Group Risk |
|
|
160 | (5) |
|
|
|
|
|
|
|
|
|
Requiring Birth Control to Participate in Research |
|
|
165 | (4) |
|
|
|
|
|
|
|
|
|
Privacy and Confidentiality |
|
|
169 | (7) |
|
|
|
|
|
Recruitment of Research Subjects |
|
|
176 | (4) |
|
|
|
|
|
|
|
|
|
Advertisements for Research |
|
|
180 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
185 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provisions for Data Monitoring |
|
|
191 | (6) |
|
|
|
|
|
Conflict of Interest: Researchers |
|
|
197 | (7) |
|
|
|
|
|
Conflict of Interest: Recruitment Incentives |
|
|
204 | (4) |
|
|
|
|
|
Conflict of Interest: IRBs |
|
|
208 | (6) |
|
|
|
|
|
Administrative Tasks Before the Meeting |
|
|
214 | (5) |
|
|
|
|
|
|
|
|
|
Guidelines for Review, Discussion, and Voting |
|
|
219 | (7) |
|
|
|
|
|
|
|
|
|
Administrative Tasks After Each IRB Meeting |
|
|
226 | (5) |
|
|
|
|
|
|
|
|
PART 6 Informed Consent |
|
231 | (56) |
|
The IRB's Role in Editing the Consent Document |
|
|
233 | (3) |
|
|
|
|
|
|
236 | (3) |
|
|
|
|
|
Exculpatory Language in Informed Consent Documents |
|
|
239 | (3) |
|
|
|
|
|
|
|
|
|
Requiring a Witness Signature on the Consent Form |
|
|
242 | (2) |
|
|
|
|
|
|
|
|
|
Deception of Research Subjects |
|
|
244 | (6) |
|
|
|
|
|
|
|
|
|
Research Without Consent or Documentation Thereof |
|
|
250 | (6) |
|
|
|
|
|
Active Versus Passive Consent |
|
|
256 | (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Selecting a Surrogate to Consent to Medical Research |
|
|
258 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research-Related Injuries |
|
|
265 | (3) |
|
|
|
|
|
Informing Subjects About Research Results |
|
|
268 | (4) |
|
|
|
|
|
Explaining the Cost of Research Participation |
|
|
272 | (5) |
|
|
|
|
|
Improving Informed Consent |
|
|
277 | (5) |
|
|
|
|
|
|
|
|
|
Informed Consent Evaluation Feedback Tool |
|
|
282 | (5) |
|
|
|
|
|
|
|
|
PART 7 Continuing Review |
|
287 | (24) |
|
Revisions of an Approved Protocol |
|
|
289 | (4) |
|
|
|
|
|
|
293 | (4) |
|
|
|
|
|
IRB Review of Adverse Events |
|
|
297 | (6) |
|
|
|
|
|
|
|
|
|
Christopher J. Kratochvil |
|
|
|
|
|
|
|
|
|
Data and Safety Monitoring |
|
|
303 | (3) |
|
|
|
|
|
Noncompliance/Complaint Procedure |
|
|
306 | (5) |
|
|
|
|
PART 8 Administrative and Regulatory Issues |
|
311 | (60) |
|
OHRP Federal-Wide Assurance |
|
|
313 | (3) |
|
|
|
|
|
International Conference on Harmonisation |
|
|
316 | (5) |
|
|
|
|
|
|
|
|
|
|
321 | (2) |
|
|
|
|
|
Understanding the FDA's IND Process |
|
|
323 | (6) |
|
|
|
|
|
Differences Between DHHS and FDA Regulations |
|
|
329 | (2) |
|
|
|
|
|
Veterans Administration Research Guidelines |
|
|
331 | (8) |
|
|
|
|
|
|
339 | (3) |
|
|
|
|
|
|
|
|
|
|
342 | (3) |
|
|
|
|
|
|
|
|
|
Certificates of Confidentiality |
|
|
345 | (2) |
|
|
|
|
|
|
|
|
|
|
347 | (2) |
|
|
|
|
|
|
|
|
|
|
349 | (4) |
|
|
|
|
|
|
|
|
|
|
353 | (3) |
|
|
|
|
|
Certification of IRB Professionals |
|
|
356 | (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Preparing for an FDA Audit |
|
|
359 | (6) |
|
|
|
|
|
Preparing for an OHRP Site Visit |
|
|
365 | (6) |
|
|
|
|
|
|
|
|
PART 9 Issues Based on Study Population |
|
371 | (30) |
|
Research Involving Fetuses and In Vitro Fertilization |
|
|
373 | (7) |
|
|
|
|
|
Research Involving Pregnant Women |
|
|
380 | (3) |
|
|
|
|
|
Research Involving Children |
|
|
383 | (6) |
|
|
|
|
|
Research Involving Adults with Decisional Impairment |
|
|
389 | (5) |
|
|
|
|
|
Research Involving Prisoners |
|
|
394 | (5) |
|
|
|
|
|
|
|
|
|
Christopher J. Kratochvil |
|
|
|
|
|
|
|
|
|
Research Involving College Students |
|
|
399 | (2) |
|
|
|
|
|
|
|
|
PART 10 IRB Issues Based On Study Design or Category |
|
401 | (86) |
|
Qualitative Social Science Research |
|
|
403 | (4) |
|
|
|
|
|
|
407 | (8) |
|
|
|
|
|
|
415 | (4) |
|
|
|
|
|
|
419 | (5) |
|
|
|
|
|
Epidemiology/Public Health Research |
|
|
424 | (4) |
|
|
|
|
|
|
428 | (6) |
|
|
|
|
|
Research Involving a Medical Device |
|
|
434 | (7) |
|
|
|
|
|
|
441 | (2) |
|
|
|
|
|
Banking of Biological Materials for Research |
|
|
443 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Placebo-Controlled Clinical Trial |
|
|
450 | (8) |
|
|
|
|
|
|
|
|
|
Research Involving Sham Surgery |
|
|
458 | (3) |
|
|
|
|
|
Treatment-Withholding Studies in Psychiatry |
|
|
461 | (4) |
|
|
|
|
|
|
465 | (11) |
|
|
|
|
|
Research Involving Genetic Testing |
|
|
476 | (5) |
|
|
|
|
|
|
481 | (2) |
|
|
|
|
|
Alternative Medicine Research |
|
|
483 | (4) |
|
|
|
|
PART 11 Reference Material and Contact Information |
|
487 | (84) |
|
|
|
|
|
|
489 | (12) |
|
|
490 | (2) |
|
|
492 | (7) |
|
World Medical Association Declaration of Helsinki |
|
|
499 | (2) |
|
Selected U.S. Government Regulations |
|
|
501 | (33) |
|
Code of Federal Regulations: Title 45, Part 46 |
|
|
502 | (15) |
|
Code of Federal Regulations: Title 21, Part 50 |
|
|
517 | (6) |
|
Code of Federal Regulations: Title 21, Part 56 |
|
|
523 | (9) |
|
Expedited IRB Review Criteria |
|
|
532 | (2) |
|
U.S. Government Guidance and Resources |
|
|
534 | (1) |
|
|
535 | (1) |
|
|
536 | (1) |
|
Periodicals and IRB Forum |
|
|
537 | (1) |
|
|
538 | (1) |
|
|
539 | (1) |
|
|
540 | (31) |
|
|
|
|
Index |
|
571 | |